USFDA APPLICATION NUMBER - 20623 / DOSAGE - TABLET;ORAL - 50MG
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
dolasetron mesylate(UNII: U3C8E5BWKR) (dolasetron - UNII:82WI2L7Q6E) | dolasetron mesylate | 100mg | 50mg |
Inactive Ingredients
Ingredient Name | Avera McKennan Hospital | sanofi-aventis U.S. LLC | Validus Pharmaceuticals LLC |
---|---|---|---|
carnauba wax(R12CBM0EIZ) | |||
croscarmellose sodium(M28OL1HH48) | |||
ferric oxide red(1K09F3G675) | |||
ferrosoferric oxide(XM0M87F357) | |||
HYPROMELLOSES(3NXW29V3WO) | |||
LACTOSE(J2B2A4N98G) | |||
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G) | |||
MAGNESIUM STEARATE(70097M6I30) | |||
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |||
polyethylene glycols(3WJQ0SDW1A) | |||
polysorbate 80(6OZP39ZG8H) | |||
propylene glycol(6DC9Q167V3) | |||
SHELLAC(46N107B71O) | |||
STARCH, CORN(O8232NY3SJ) | |||
STARCH, PREGELATINIZED CORN(O8232NY3SJ) | |||
TITANIUM DIOXIDE(15FIX9V2JP) | |||
WHITE WAX(7G1J5DA97F) |